Compare MG & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MG | CYRX |
|---|---|---|
| Founded | 1978 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.7M | 419.3M |
| IPO Year | 2008 | 2008 |
| Metric | MG | CYRX |
|---|---|---|
| Price | $17.25 | $9.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 113.3K | ★ 399.7K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | 0.53 | ★ 1.40 |
| Revenue | ★ $700,970,000.00 | $176,177,000.00 |
| Revenue This Year | $5.47 | $11.06 |
| Revenue Next Year | $3.59 | $8.45 |
| P/E Ratio | $32.09 | ★ $7.19 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.06 | $5.21 |
| 52 Week High | $17.35 | $11.45 |
| Indicator | MG | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 74.29 | 71.24 |
| Support Level | $13.75 | $9.18 |
| Resistance Level | N/A | $10.23 |
| Average True Range (ATR) | 0.53 | 0.41 |
| MACD | 0.21 | 0.17 |
| Stochastic Oscillator | 92.97 | 90.91 |
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.